Transition Therapeutics - Ownership and Business Overview

Life ScienceCompany

Transition Therapeutics Ownership

Who owns Transition Therapeutics?

Transition Therapeutics is owned by Opko Health. It was acquired on June 30, 2016.

Was Transition Therapeutics formerly PE-backed?

Yes. Transition Therapeutics was formerly owned by 1 private investor.

Transition Therapeutics Business Overview

Where is Transition Therapeutics headquartered?

Transition Therapeutics is headquartered in Toronto, Ontario.

How many employees does Transition Therapeutics have?

Transition Therapeutics has 18 employees.

What sector is Transition Therapeutics in?

Transition Therapeutics is a life science company.

When was Transition Therapeutics founded?

Transition Therapeutics was founded in 1987.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.

Transition Therapeutics, Inc.

101 College Street Suite 220,
Toronto, Ontario M5G 1L7
Canada,
(416) 260-7770
www.transitiontherapeutics.com

Transition Therapeutics Inc. is a bio pharmaceutical company, develops therapeutics for various disease indications. Transition Therapeutics, Inc. was formed in 1987 and is based in Toronto, Ontario.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.